Pacer Advisors Inc. trimmed its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 13.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,783 shares of the insurance provider’s stock after selling 2,010 shares during the quarter. Pacer Advisors Inc.’s holdings in Humana were worth $3,274,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of HUM. Montag A & Associates Inc. boosted its stake in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC increased its stake in Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new stake in Humana during the 4th quarter worth approximately $27,000. Rosenberg Matthew Hamilton lifted its holdings in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after buying an additional 68 shares in the last quarter. Finally, Larson Financial Group LLC lifted its holdings in Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after buying an additional 81 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have commented on the stock. UBS Group restated a “neutral” rating on shares of Humana in a research note on Monday, June 15th. Guggenheim lifted their target price on Humana from $252.00 to $269.00 and gave the company a “buy” rating in a report on Thursday, April 30th. Seaport Research Partners cut Humana to a “neutral” rating in a research note on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Finally, Royal Bank Of Canada restated a “sector perform” rating on shares of Humana in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, Humana currently has a consensus rating of “Hold” and a consensus price target of $291.35.
Humana Stock Down 0.2%
Humana stock opened at $359.99 on Wednesday. The stock has a market cap of $43.22 billion, a PE ratio of 38.50, a P/E/G ratio of 2.05 and a beta of 0.76. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock’s fifty day moving average is $292.50 and its two-hundred day moving average is $243.15. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $380.86.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. During the same period in the prior year, the firm posted $11.58 EPS. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts expect that Humana Inc. will post 9.04 EPS for the current fiscal year.
Humana Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
